Sign inJoin waitlistJoin the waitlist

JP

Joel Pearlman

Physician · Retina Consultants of America

Credentials: · · · ·

History

Retina Consultants of America
Present

Ophthalmology
Johns Hopkins University School of Medicine
1996–1999
Preliminary or Transitional Year
1995–1996
Baylor College of Medicine
1991–1995

Research

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Case report · Ophthalmology · 2006 · 550 citations
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease
JCI Insight · 2017 · 409 citations
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial
Ophthalmology · 2021 · 375 citations

DB
David Boyer
4 papers
Glenn Jaffe
4 papers
KC
Karl Csaky
4 papers
PD
Pravin Dugel
4 papers
BJ
Brian Joondeph
3 papers
DP
Dante Pieramici
3 papers
JR
John Randolph
3 papers
Kouros Rezaei
3 papers
PC
Peter Campochiaro
3 papers
SP
Sunil Patel
3 papers
Andre Witkin
2 papers
DB
David Brown
2 papers

Clinical trials

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
Principal investigator · Completed · Phase 2
Retinal Consultants Medical Group
2006
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Site PI · Recruiting · Phase 3
4D Molecular Therapeutics
2025–2029
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Site PI · Recruiting · Phase 1, Phase 2
4D Molecular Therapeutics
2021–2031